Bone Therapeutics ALLOB Phase I/IIA Delayed-Union Fracture Trial Update
Bone Therapeutics reports positive interim efficacy results and early conclusion of the Phase I/IIA study of ALLOB® allogeneic bone cell therapy in the treatment of delayed-union fractures. Sep 20, 2017